Vikash Kumar

Vikash Kumar practices at Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia.

Vikash Kumar's NPI, 1861045981, was assigned on July 17, 2019. Vikash Kumar holds West Virginia license 31327.

Vikash Kumar's primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD, at 33 Medical Center Dr, Morgantown, WV 26505.

Vikash Kumar's primary practice is Rockefeller Neuroscience Institute - Neurology - HOPD in Morgantown, West Virginia. Vikash Kumar is also affiliated with J.W. Ruby Memorial Hospital. The medical group on file is University Health Associates. Dmand AI also links Vikash Kumar to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Vikash Kumar practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Vikash Kumar's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Vikash Kumar is licensed in West Virginia.

CMS data shows 404 Medicare services from Vikash Kumar across 8 procedure codes in 2024, for 224 Medicare patients. Medicare paid $32,558 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 224 Medicare patients who saw Vikash Kumar in 2024. The largest group is 75 to 84, with 85 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Vikash Kumar's median patient age at 72, with 47% women.

In 2024, Vikash Kumar wrote 197 Medicare Part D claims for 81 patients. 84% of them were for generic drugs. CMS names the drug for 34 of them, across 2 drugs with 11 or more claims each, at $354 in total drug cost. In 2023, CMS named 24 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Vikash Kumar for performance year 2024, reported through an alternative payment model (APM). Vikash Kumar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 154 papers to Vikash Kumar, published from 2011 to 2025. 2023 was the busiest year, with 26. The most frequent topics are Models, Molecular, Leishmania donovani and Leishmaniasis, Visceral. Vikash Kumar has published most often in Cureus. Vikash Kumar's most frequent co-authors are Mohammad I. Siddiqi, MD, Madhavi Reddy, MD and Madhavi Reddy, MD.

CMS Open Payments shows 5 general payments to Vikash Kumar from 2 drug and device companies from 2022 to 2024. Food and beverage make up the largest share, 100% of the total. Gilead Sciences, Inc. paid the most, $403.